Combination Therapy Significantly Improved BPH Symptoms in Men, Study Finds
News
A combination therapy composed of a 5-alpha-reductase inhibitor and an alpha-blocker provides significant improvements in men with benign prostatic hyperplasia (BPH), according to a new study. But a high percentage ... Read more